265 related articles for article (PubMed ID: 28003005)
1. Targeting Cysteine Proteases from Plasmodium falciparum: A General Overview, Rational Drug Design and Computational Approaches for Drug Discovery.
Bekono BD; Ntie-Kang F; Owono Owono LC; Megnassan E
Curr Drug Targets; 2018; 19(5):501-526. PubMed ID: 28003005
[TBL] [Abstract][Full Text] [Related]
2. Falcipain inhibition as a promising antimalarial target.
Marco M; Coterón JM
Curr Top Med Chem; 2012; 12(5):408-44. PubMed ID: 22242849
[TBL] [Abstract][Full Text] [Related]
3. Falcipains, Plasmodium falciparum cysteine proteases as key drug targets against malaria.
Teixeira C; Gomes JR; Gomes P
Curr Med Chem; 2011; 18(10):1555-72. PubMed ID: 21428877
[TBL] [Abstract][Full Text] [Related]
4. The impact of whole genome sequence data on drug discovery--a malaria case study.
Joachimiak MP; Chang C; Rosenthal PJ; Cohen FE
Mol Med; 2001 Oct; 7(10):698-710. PubMed ID: 11713369
[TBL] [Abstract][Full Text] [Related]
5. Cysteine proteases of malaria parasites.
Rosenthal PJ
Int J Parasitol; 2004 Dec; 34(13-14):1489-99. PubMed ID: 15582526
[TBL] [Abstract][Full Text] [Related]
6. Falcipains and other cysteine proteases of malaria parasites.
Rosenthal PJ
Adv Exp Med Biol; 2011; 712():30-48. PubMed ID: 21660657
[TBL] [Abstract][Full Text] [Related]
7. Three Decades of Targeting Falcipains to Develop Antiplasmodial Agents: What have we Learned and What can be Done Next?
González JEH; Salas-Sarduy E; Alvarez LH; Valiente PA; Arni RK; Pascutti PG
Curr Med Chem; 2024; 31(16):2234-2263. PubMed ID: 37711130
[TBL] [Abstract][Full Text] [Related]
8. Hemoglobin Degrading Proteases of Plasmodium falciparum as Antimalarial Drug Targets.
Qidwai T
Curr Drug Targets; 2015; 16(10):1133-41. PubMed ID: 25738296
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Plasmodium falciparum cysteine proteases by the sugarcane cystatin CaneCPI-4.
Melo PMS; El Chamy Maluf S; Azevedo MF; Paschoalin T; Budu A; Bagnaresi P; Henrique-Silva F; Soares-Costa A; Gazarini ML; Carmona AK
Parasitol Int; 2018 Apr; 67(2):233-236. PubMed ID: 29288140
[TBL] [Abstract][Full Text] [Related]
10. Falcipain cysteine proteases of malaria parasites: An update.
Rosenthal PJ
Biochim Biophys Acta Proteins Proteom; 2020 Mar; 1868(3):140362. PubMed ID: 31927030
[TBL] [Abstract][Full Text] [Related]
11. BDA-410: a novel synthetic calpain inhibitor active against blood stage malaria.
Li X; Chen H; Jeong JJ; Chishti AH
Mol Biochem Parasitol; 2007 Sep; 155(1):26-32. PubMed ID: 17583361
[TBL] [Abstract][Full Text] [Related]
12. Falcipain inhibitors as potential therapeutics for resistant strains of malaria: a patent review.
Mane UR; Gupta RC; Nadkarni SS; Giridhar RR; Naik PP; Yadav MR
Expert Opin Ther Pat; 2013 Feb; 23(2):165-87. PubMed ID: 23228154
[TBL] [Abstract][Full Text] [Related]
13. Pyrido[1,2-a]pyrimidin-4-ones as antiplasmodial falcipain-2 inhibitors.
Mane UR; Li H; Huang J; Gupta RC; Nadkarni SS; Giridhar R; Naik PP; Yadav MR
Bioorg Med Chem; 2012 Nov; 20(21):6296-304. PubMed ID: 23040894
[TBL] [Abstract][Full Text] [Related]
14. Identification of antimalarial leads with dual falcipain-2 and falcipain-3 inhibitory activity.
Rana D; Kalamuddin M; Sundriyal S; Jaiswal V; Sharma G; Das Sarma K; Sijwali PS; Mohmmed A; Malhotra P; Mahindroo N
Bioorg Med Chem; 2020 Jan; 28(1):115155. PubMed ID: 31744777
[TBL] [Abstract][Full Text] [Related]
15. Falcipains: Biochemistry, target validation and structure-activity relationship studies of inhibitors as antimalarials.
Patra J; Rana D; Arora S; Pal M; Mahindroo N
Eur J Med Chem; 2023 Apr; 252():115299. PubMed ID: 36996716
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel class of falcipain-2 inhibitors as potential antimalarial agents.
Chakka SK; Kalamuddin M; Sundararaman S; Wei L; Mundra S; Mahesh R; Malhotra P; Mohmmed A; Kotra LP
Bioorg Med Chem; 2015 May; 23(9):2221-40. PubMed ID: 25840796
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel malarial cysteine protease inhibitors using structure-based virtual screening of a focused cysteine protease inhibitor library.
Shah F; Mukherjee P; Gut J; Legac J; Rosenthal PJ; Tekwani BL; Avery MA
J Chem Inf Model; 2011 Apr; 51(4):852-64. PubMed ID: 21428453
[TBL] [Abstract][Full Text] [Related]
18. A prodomain peptide of Plasmodium falciparum cysteine protease (falcipain-2) inhibits malaria parasite development.
Korde R; Bhardwaj A; Singh R; Srivastava A; Chauhan VS; Bhatnagar RK; Malhotra P
J Med Chem; 2008 Jun; 51(11):3116-23. PubMed ID: 18461922
[TBL] [Abstract][Full Text] [Related]
19. Antimalarial activities of novel synthetic cysteine protease inhibitors.
Lee BJ; Singh A; Chiang P; Kemp SJ; Goldman EA; Weinhouse MI; Vlasuk GP; Rosenthal PJ
Antimicrob Agents Chemother; 2003 Dec; 47(12):3810-4. PubMed ID: 14638488
[TBL] [Abstract][Full Text] [Related]
20. Falcipain inhibitors: optimization studies of the 2-pyrimidinecarbonitrile lead series.
Coterón JM; Catterick D; Castro J; Chaparro MJ; Díaz B; Fernández E; Ferrer S; Gamo FJ; Gordo M; Gut J; de las Heras L; Legac J; Marco M; Miguel J; Muñoz V; Porras E; de la Rosa JC; Ruiz JR; Sandoval E; Ventosa P; Rosenthal PJ; Fiandor JM
J Med Chem; 2010 Aug; 53(16):6129-52. PubMed ID: 20672841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
